| Novartis Pharma Schweiz AG - Lutathera CA 370 MBq/ml, Infusionslösung | | 66580 | | 01 | | Lutathera CA 370 MBq/ml | | Infusionslösung | | V10XX04 | | Lutetium (177lu) Oxodotreotide | | 25.06.2019 | | |
| | Composition | | lutetium(177-Lu(CA)) oxodotreotidum 370 MBq, acidum aceticum, natrii acetas, acidum penteticum, natrii chloridum, natrii hydroxidum, acidum gentisicum, E 300, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.24 mg. | | Packungsbestandteile | | Infusion solution | | | | | | | | Active Agent | Dose |
|---|
| Lutetium(177lu(Ca)) Oxodotreotidum | 370 MBq/ml |
| | BAG: Active Agent | Dose |
|---|
| Lutetium-177 Oxodotreotidum | 370 MBq |
| | | | Inactive agents |
|---|
| Acetic Acid | | Acidum Gentisicum | | Acidum Penteticum | | E 300 | | Sodium Acetate | | Sodium Chloride | | Sodium Hydroxide |
| |
| |
|
